Company Filing History:
Years Active: 2003
Title: Joseph B Mandeville: Innovator in Psychostimulant Craving Inhibition
Introduction
Joseph B Mandeville is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of addiction research, particularly in the inhibition of cravings induced by psychostimulants and nicotine. His work aims to provide effective methods for individuals struggling with substance dependence.
Latest Patents
Mandeville holds a patent for the invention titled "Inhibition of psychostimulant-induced and nicotine-induced craving." This invention outlines methods for inhibiting cravings for additional psychostimulants, such as cocaine or amphetamine, as well as nicotine. The methods involve administering D1-like antagonists or D1-like agonists to patients who are dependent on these substances. Additionally, the patent describes an animal model system that can measure the effectiveness of test compounds in inhibiting cravings in humans.
Career Highlights
Joseph B Mandeville is associated with The General Hospital Corporation, where he continues to advance research in addiction and craving inhibition. His innovative approaches have the potential to impact treatment strategies for individuals facing substance use disorders.
Collaborations
Mandeville has collaborated with esteemed colleagues, including Hans C Breiter and Bruce R Rosen. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatment methods.
Conclusion
Joseph B Mandeville's work in the field of psychostimulant craving inhibition represents a significant advancement in addiction research. His innovative methods and collaborations contribute to the ongoing efforts to address substance dependence effectively.